An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face
Publication:
Clinics in Dermatology
Date:
November–December 2009
Copyright © 2009 Elsevier Inc. All rights reserved.